Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper Egypt

BACKGROUND: Egypt is considered a region of the intermediate prevalence of hepatitis B virus (HBV) infection (4.5%). Seroprotection is assured when hepatitis B surface antibody (HBsAb) levels are ≥ 10 mIU/mL. Our study aimed to evaluate and compare the long-term immunogenicity and efficacy of the re...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Asheer, Osama M., Darwish, Manal M., Abdou, Madleen A., Saad, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040530/
https://www.ncbi.nlm.nih.gov/pubmed/27785300
http://dx.doi.org/10.14740/gr636e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040530/
https://www.ncbi.nlm.nih.gov/pubmed/27785300
http://dx.doi.org/10.14740/gr636e

Ejemplares similares